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ABSTRACT 
Objective: The objective of this study was to design and evaluate controlled release mucoadhesive microspheres of lamivudine using mucoadhesive 
polymers and mucilage.  
Methods: Mucoadhesive microspheres of lamivudine were formulated by ionic gelation method. The response surface methodology was adapted 
for optimization of formulation using central composite design (CCD) for two factors at three levels each was employed to study the effect of 
independent variables, Sodium alginate-drumstick mucilage (X1) and calcium chloride (CaCl2) concentration (X2) on dependent variables, namely 
drug encapsulation efficiency (DEE) and particle size (PS). Optimized drumstick mucilage mucoadhesive microspheres of lamivudine were obtained 
by using numerical optimization of desirability approach. The observed microspheres were coincided well with the predicted values by the 
experimental design. 
Results: The microspheres formed were spherical in shape, and Particle size (PS) ranged between 681.63-941.57μm. Drug encapsulation efficiency 
(DEE) was ranged between 69.63-94.56 %. The drug release for an optimized formulation was 96.58 %. The mechanism of drug release from 
microspheres followed Korsemeyer’s-Peppas and exponential ‘n’ value was greater than 0.45, indicating the drug release was non-fickian i.e., 
swelling followed by erosion mechanism. 
Conclusion: This work suggests that mucoadhesive microspheres, an effective drug delivery system for lamivudine, can be prepared using 
drumstick mucilage in improving the bioavailability of the drug. 
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The main goal of drug delivery systems is to achieve a desired 
concentration of the drug in blood or tissue, which is therapeutically 
effective and non-toxic for a prolonged period. The most preferable 
route of drug delivery is oral drug delivery, due to its ease of 
administration, patient compliance, and flexibility in the formulations. 
The major objective of oral controlled drug delivery system is to 
deliver drugs for a longer period of time to achieve better 
bioavailability, which should be predictable and reproducible [1]. 
The mucoadhesive polymer containing oral drug delivery systems 
has the capacity to prolong the residence time of drugs at the 
absorption site and facilitate intimate contact with an underlying 
absorptive surface to enhance bioavailability [2]. Polymers used in 
the mucoadhesive formulations include natural, semi-synthetic, and 
synthetic ones. In recent years, a growing interest has been 
identified in the development of natural polymer-based drug 
delivery systems due to their biodegradability, biocompatibility, 
aqueous solubility, swelling ability, easy availability, and cost-
effectiveness [3]. Amongst various natural polymers, alginates have 
been widely used in the development of drug delivery applications 
[4-7]. It is composed of linear copolymers of two monomeric units, 
that is, -D-mannuronic acid and -L-guluronic acid [8]. Sodium 
alginate undergoes ionotropic-gelation by Ca2+to form calcium 
alginate due to an ionic interaction between carboxylic acid groups 
of alginate chain and Ca2+ [9]. Sodium alginate has mucoadhesive 
property; however, the cross-linked alginates are usually fragile [10, 
11]. Therefore, the blending of different mucoadhesive polymers is 
one of the most popular approaches to formulate ionotropically 
cross-linked alginate-based mucoadhesive spheres [10, 12, 13]. 
Again, blending with suitable polymers, may improve the drug 
encapsulation, which is found comparatively lower in alginate-based 
microspheres prepared by ionotropic-gelation method [7]. 
Drumstick is a rich source of the polysaccharide galactomannan. 
Drumstick is a source of saponins such as diosgenin, yamogenin, 
gitogenin, tigogenin, and neotigogens, other bioactive constituents of 
moringa include mucilage, volatile oils, and alkaloids such as choline 
and trigonelline. Mucilage is obtained from stem and pods 
of moringa oleifera (family: Moringaceae). The mucilage is a 
polyuronide constituting of arabinose, galactose, and glucuronic acid 
in the proportion of 10:7:2, rhamnose present in traces. The gelling 
concentration of the mucilage was found to lie between 7 and 
8.5% w/v. The mucilage exhibited pseudoplastic flow and viscosity 
were found to be ideal for topical application [14], binding property 
and release retardant property [15]. 
Lamivudine is a synthetic nucleoside analog that is being 
increasingly used as the core of an antiretroviral regimen for the 
treatment of HIV infection [16, 17]. In vivo, nucleoside analogs are 
phosphorylated intracellularly by endogenous kinases to putatively 
active 5′-triphosphate (3TC-TP) derivatives that prevent HIV 
replication by competitively inhibiting viral reverse transcriptase 
and terminating proviral DNA chain extension [18-20]. Lamivudine 
is rapidly absorbed after oral administration with an absolute 
bioavailability of 86%±16%, peak serum concentration of 
lamivudine (Cmax) of 1.5±0.5µg/ml and mean elimination half-life 
(t½) of 5 to7 h, thus necessitating frequent administration to 
maintain constant therapeutic drug levels [21]. 
Therefore, it would be beneficial to develop a mucoadhesive system of 
lamivudine using drumstick-alginate for oral use, which might facilitate 
an intimate contact with the mucous membranes (i.e., mucoadhesion or 
bioadhesion) and thus the release of lamivudine at a controlled rate over 
an extended period to maximize the therapeutic effect. 
In the development of any pharmaceutical formulation, an important 
issue is to design a formulation with optimized quality in a short 
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time period and a minimum number of trials [22, 23]. Traditionally, 
research formulators produce formulation by changing only one 
variable at a time while keeping other variables fixed. This classical 
method is laborious and time-consuming. Therefore, it is essential to 
understand the influence of formulation ingredients or factors on 
the properties of formulations with a minimal number of 
experimental trials and subsequent selection of formulation 
ingredients or factors to develop an optimized formulation using 
established statistical tools [6, 24-26]. Factorial designs, where all the 
factors are studied in all possible combinations, are considered the 
most efficient in estimating the influence of individual factors and their 
interactions performing minimum numbers of experiments [27]. A 
computer-aided optimization technique based on 32(two factors and 
three levels) factorial design and response surface methodology was 
employed to investigate the effects of two independent process 
variables (ingredients or factors), i.e., sodium alginate-drumstick 
mucilage ratio and concentration of CaCl2 on the properties of 
ionotropically gelled drumstick mucilage-alginate mucoadhesive 
microspheres of lamivudine such as DEE and PS of microsphere. 
MATERIALS AND METHODS 
Materials 
Lamivudine obtained as gift sample from Hetero Drugs Private Ltd, 
Sodium alginate and calcium chloride were procured from yarrow 
chemicals and SD fine chemicals Mumbai respectively. Drumstick 
pods were procured from local market. All other reagents used were 
of analytical grades and double distilled water was used throughout 
the studies. 
Method 
Isolation of drumstick powder mucilage 
Mucilage was isolated from the pods of Moringa oleifera Lam. (500g) 
by dissolving it in distilled water. Further, it was boiled for 1 h under 
reflux with occasional stirring and kept aside for 2 h for the release 
of mucilage into water then filtered. The filtrate was precipitated out 
with ethanol in crude form. The precipitated material was filtered 
through a muslin bag into conical flask and marc is squeezed well in 
order to remove the mucilage completely, in between hot distilled 
water (25 ml) was added through the sides of muslin bag. The 
aqueous filtrate is concentrated to 1/3rd of its volume; mucilage is 
precipitated by adding an equal volume of ethanol. The obtained 
precipitate is settled by keeping in a refrigerator for overnight. After 
complete settling of the precipitate, it was filtered and dried the 
residue at 37 °C. The obtained dried powder was reduced to fine 
powder and passes through 120# and subjected for identification 
test to confirm its identity. The prepared drumstick mucilage 
powder was stored in desiccators for further study [28, 29]. 
Preparation of drumstick mucilage-alginate mucoadhesive 
microspheres of lamivudine by orifice ionic gelation method 
The drumstick mucilage-alginate mucoadhesive microspheres of 
lamivudine were prepared by the ionotropic-gelation technique 
using CaCl2 as cross-linker. Sodium alginate and drumstick mucilage 
aqueous dispersions were prepared separately using distilled water. 
These dispersions were mixed well with stirring for 15 min. 
Lamivudine was added to the dispersion mixture, the ratio of drug to 
polymer was maintained 1: 2 in all formulations. The resulting 
dispersion was then added via a 21-gauge needle into 100 ml of 
CaCl2 solution. The added droplets were retained in the CaCl2 
solution for 15 min to complete the curing reaction and to produce 
rigid spheres. The wet spheres were collected by decantation and 
washed two times with distilled water and dried at 37 °C for 24 h. 
The dried drumstick mucilage-alginate mucoadhesive microspheres 
of lamivudine were stored in desiccators until used [30].  
Experimental design for optimization 
A 32factorial design was employed for optimization with sodium 
alginate: drumstick mucilage (X1) and concentration of CaCl2 (x2) as 
selected independent variables, which were varied at three levels, low 
(–1), medium (0), and high (+1). The DEE,(%) and PS (µm) were used 
as dependent variables (responses). Design-Expert Demo Version 11 
software (Stat-Ease In C., USA) was used for the generation and 
evaluation of the statistical experimental design. The batches were 
prepared as per design and investigated responses, i.e., DEE and PS 
were shown in table 1. The effects of independent variables upon the 
all measured responses were modeled using the following quadratic 
mathematical model generated by 32factorial designs [6]. 
Y= b0+b1X1+b2X2+b3X1X2+b4X12+b5X22 
Where Y is the response, b0 is the intercept, and b1, b2, b3, b4, b5 are 
regression coefficients. X1 and X2 are individual effects. X12and X22are 
model quadratic effects; X1X2 is the interaction effects. One-way 
ANOVA was applied to estimate the significance (P<0.05) of 
generated models. Individual response parameters were evaluated 
using the F-test. The response surface methodology was applied to 
analyze the effect of independent factors (SA: Drumstick mucilage 
and CaCl2) on the measured responses (DEE and PS). 
 
Table 1: Plan of 32 factorial designs with responses for different drumstick mucilage-alginate mucoadhesive microspheres of lamivudine 
Batch code Normal input variables Responses 
Sodium alginate: drumstick mucilage(X1) CaCl2 (%)(X2) DEE (%) PS (µm) 
F-1 4 5 74.89 885.12 
F-2 1 7.5 79.05 779.36 
F-3 4 10 69.63 941.57 
F-4 1 5 85.26 749.63 
F-5 4 7.5 79.59 812.85 
F-6 2.5 10 82.79 790.86 
F-7 2.5 7.5 94.56 681.63 
F-8 2.5 5 73.82 844.39 




All the batches of dried microspheres were accurately weighed 
separately and percentage yield is calculated by using the given equation. 
 
Determination of DEE (%) 
Accurately weighed, 100 mg of microspheres were taken and were 
crushed using pestle and mortar. The crushed powders of drug-
containing microspheres were placed in 500 ml of phosphate buffer 
pH 7.4 and kept for 24 h with occasional shaking at 37±0.5 °C. After 
the stipulated time, polymer debris formed after the disintegration 
of microspheres was removed by filtration. The drug content in the 
filtrate was determined using a UV-VIS spectrophotometer 
(Shimadzu, Japan) at 271 nm. The DEE of microspheres was 
calculated using the following formula:  
 
PS measurement 
PS and size distribution of mucoadhesive microspheres of 
lamivudine were measured by sieve analysis using mechanical 
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sieve shaker. Different sizes in a batch are separated by sieve 
using a range of standard sieves 10/22, 22/44 and the amounts 
retained on different sieves were weighed. The sizes of the 
microspheres were determined by carrying out studies in 
triplicate and its average size is calculated by using the given 
following equation. 
 
Where, Xi-Mean size range;  
fi-Percentage microspheres retained on the smaller sieve range. 
Surface morphology studies of microspheres by scanning 
electron microscopy 
The PS, shape and surface morphology of optimized mucoadhesive 
microspheres were examined by scanning electron microscopy. 
Mucoadhesive microspheres were fixed on aluminum studs and 
coated with gold using a sputter coater SC 502, under vacuum [0.1 
mm Hg] and are analyzed using-Model JSM-840 A, Joel. Japan. 
In vitro drug release studies 
The release of optimized formulation drumstick mucilage-alginate 
microspheres of lamivudine and marketed tablet viz., Lamivir were 
tested using a dissolution test apparatus USP-I. The baskets were 
covered with cloth to prevent microspheres to escape out. The 
dissolution rates were measured at 37±1 °C at 50 rpm speed. 
Drumstick mucilage-alginate microspheres of lamivudine equivalent to 
50 mg of lamivudine were taken in 900 ml of dissolution medium 
(phosphate buffer, pH 7.4). An amount of 5 ml of aliquots was collected 
at regular time intervals and the same amount of fresh phosphate buffer 
pH 7.4 medium was replaced into the dissolution vessel to maintain sink 
condition throughout the experiment. The collected aliquots were 
filtered and suitably diluted to determine absorbance using a UV-VIS 
spectrophotometer (Shimadzu, Japan) at 271 nm against a blank 
(phosphate buffer, pH 7.4). In order to predict and correlate the in vitro 
release behavior of lamivudine from optimized formulation drumstick 
mucilage–alginate microspheres and marketed tablet Lamivir, data were 
fitted into a suitable mathematical model. The studies were carried out 
in triplicate. The in vitro dissolution data were tabulated and computed 
by using dissolution software viz., PCP DISSO V3.0. 
  
Table 2: Report of ANOVA of responses for DEE and PS 
Source Sum squares df Mean square F value P value probe>F 
For DEE(%) 
Model 472.54 5 94.51 2583.27 <0.0001 
X1 171.74 1 171.74 4694.23 <0.0001 
X2 293.02 1 293.02 8009.48 <0.0001 
X1X2 0.8190 1 0.8190 22.39 0.0179 
X21 1.83 1 1.83 50.03 0.0058 
X22 5.13 1 5.13 140.24 0.0013 
For PS(µm) 
Model 53928.47 5 10785.69 198.27 0.0006 
X1 23242.91 1 23242.91 427.28 0.0002 
X2 28505.31 1 28505.31 524.02 0.0002 
X1X2 94.97 1 94.97 1.75 0.2781 
X21 1976.95 1 1976.95 36.34 0.0091 
X22 108.34 1 108.34 1.99 0.2530 
 
RESULTS AND DISCUSSION 
Mucilage was isolated from drumstick (Moringa oleifera) pod and 
the average yield of mucilage was found 5.86% w/w. For the 
32factorial design, a total of 9 trial formulations were proposed by 
Design-Expert Demo Version 11 software (Stat-Ease Inc., USA). 
According to this trial proposal, various drumstick mucilage-alginate 
microspheres of lamivudine were prepared by ionotropic gelation 
technique. When various dispersion mixtures containing different 
polymer-blend (Sodium alginate and Drumstick mucilage) and 
lamivudine were dropped into the solutions containingCaCl2, 
drumstick mucilage-alginate of lamivudine microspheres were 
formed instantaneously due to the electrostatic interaction between 
alginate ions and calcium ions present in the cross-linking solutions. 
The values of DEE and PS of microspheres, measured for all the 
formulations reported in table 1, were fitted in the 32factorial design 
to get model equations. The Design-Expert Demo Version 11 
software (Stat-Ease InC., USA) provided quadratic model equations 
involving individual main factors and interaction factors for all 
response parameters. The results of the ANOVA given in table 2, 
showing these models were significant for all response parameters.  
The model equation relating 
DEE (%) =79.09-5.35X1+6.98X2-0.4525X1X2+0.9567X12+1.60X22(�2= 
0.9908; F value = 2583.27; <0.05). 
The model equation relating  
PS (µm) = 783.74+62.4X1-68.93X2-4.87X1X2− 31.44X12−7.36X22 (R2= 
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Fig. 1: Linear correlation plot containing DEE (%) between the actual and the predicted values 
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Normal Plot of Residuals













Fig. 2: Normal residual plot containing DEE (%) showing the scatter of the residuals versus predicted values 
 
The influences of main effects (factors) on responses DEE and PS 
were further elucidated by response surface methodology. Response 
surface methodology is a widely proficient approach in the 
development and optimization of drug delivery devices [6, 9, 31]. 
Response surface methodology encompasses the generation of 
model equations of the investigated responses over the 
experimental domain to determine optimum formulation (s) [32]. 
The three-dimensional response surface plot is very useful in 
learning about the main and interaction effects of the independent 
variables (factors), whereas two-dimensional contour plot gives a 
visual representation of values of the response [5]. The three-
dimensional response surface plot of DEE (fig. 5) shows the 
increment of DEE with the lowering of sodium alginate-drumstick 
mucilage (X1) and increasing of CaCl2 concentration(X2). However, an 
increase in PS with the increment in sodium alginate-drumstick 
mucilage(X1) and lowering of CaCl2 concentration (X2) is shown by 
the three-dimensional response surface plot containing PS as shown 
in fig. 7. Contour plots as shown in fig. 6 and 8, showed responses of 
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Fig. 4: Normal residual plot containing PS (µm) showing the scatter of the residuals versus predicted values 
 
Numerical optimization technique with the desirability approach was 
used to develop optimized formulations for the desired response 
(optimum quality). The desirable ranges of the responses DEE targeted 
to maximum (90.00 ≤ DEE ≤ 100.00%) and PS minimized to 
(650.00≤Particle size≤750.00 µm). The optimal values of responses were 
obtained by numerical analysis using the Design-Expert Demo Version 
11 software (Stat-Ease InC., USA) based on the criterion of desirability. 
The desirability plot showing desirable regression ranges for variable 
settings of the optimization process was given in fig. 9, and overlay plot 
showing the region of variable settings of the optimization process was 
shown in fig. 10. In order to evaluate the optimization capability of these 
models generated according to the results of 32factorial design, 
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optimized drumstick mucilage-alginate microspheres of lamivudine 
were prepared using one of the variable settings of the optimization 
process proposed by the design (prediction R2= 1). The selected variable 
settings of the optimization process were used for the formulation 
containing X1= 1.24 and X2= 9.36. The optimized microspheres 
containing lamivudine (F-Optimised) were evaluated for DEE (%) and PS 
(µm). The results of experiments with predicted responses by the 
mathematical models and those actually observed for optimized 
formulation were shown in table 3. The optimized drumstick-alginate 
microspheres of lamivudine (F-Optimised) showed DEE of 
92.106±3.96% and PS 724.68 µm±5.65% with small error values (0.125 
and 4.817 resp), indicating that mathematical models obtained from the 
32factorial design were fitted well. 
The DEE (%) of all these drumstick mucilage-alginate microspheres 
of lamivudine was within the range between 69.63±1.77 and 
94.56±4.80% w/w (Tables 1 and 3). It was observed that DEE (%) 
was increased with the lowering of sodium alginate: drumstick 
mucilage blend, which may be due to an increase in viscosity of the 
solution by the addition of drumstick mucilage. This may be due to 
blocking of drug leaching to the cross-linking solution and the 
increase of cross-linking by CaCl2. 
The average microsphere size of drumstick mucilage-alginate 
microspheres of lamivudine was within the range of 681.63±5.06 to 
941.57±4.12 µm (table 1). Increase in the average size of 
microspheres was found with the increasing proportion of 
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Fig. 7: Response surface plot, showing effect of sodium alginate-drumstick mucilage and concentration of CaCl2 on particle size 
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X1 = A: Sodium Alginate: Drumstick
X2 = B: Calcium Chloride































Fig. 8: Contour plot showing, the effect of sodium alginate-drumstick mucilage and concentration of CaCl2 on particle size 
 
Table 3: Results of actual and predicted values for DEE and PS responses at optimized conditions 
Batch code Sodium alginate: drumstick mucilage CaCl2 % DEE% PS (µm) 
 Actual values 
F-Opt 1.240 9.364 90.652 701.199 
 Predicted values 
92.106 724.68 
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Fig. 10: The overlay plot showing the variable settings for the region of process optimization 
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Fig. 11: Scanning electron microphotograph of optimized drumstick mucilage-alginate microspheres of lamivudine (F-Opt) 
 


































Fig. 12: In vitro comparison plots for the release of lamivudine from both optimized drumstick mucilage-alginate microspheres and 
marketed lamivir tablet 
 
This could be attributed due to the increase in viscosity of 
polymer solution with the increased proportion of drumstick 
mucilage, which increased the droplet size of polymer-blend 
solutions to the cross-linking solutions during preparation. The 
surface morphological analysis of drumstick mucilage-alginate 
microspheres of lamivudine was visualized by scanning electron 
micrograph as shown in fig. 11. The scanning electron 
micrograph of these microspheres possessed irregular shape 
without forming agglomeration. Their surface morphologies 
appeared to have a rough surface with characteristic pores, large 
wrinkles, and cracks as shown in fig. These pores, cracks, and 
wrinkles may be due to polymeric gel collapsing during the 
drying process of microspheres. 
The in vitro lamivudine release studies were carried out for 
optimized drumstick mucilage-alginate microspheres of lamivudine 
and marketed Lamivir Tablet, in the phosphate buffer pH 7.4. The 
optimized microspheres showed the release of lamivudine over a 
period of 12 h as shown in fig. 12. The release of drug lamivudine 
from these drumstick mucilage-alginate microspheres was 
controlled and prolonged in phosphate buffer (pH 7.4), due to the 
higher swelling rate of these microspheres in phosphate buffer. 
 
Table 5: Curve fitting data of the in vitro release of lamivudine from optimized drumstick mucilage-alginate mucoadhesive microspheres 
and marketed lamivir tablet 
 Marketed lamivir tablet F-Opt 
Zero order 0.8267 0.9427 
1st order 0.9978 0.9840 
Matrix 0.9890 0.9821 
Peppas 0.9809 0.9947 
Hix. Crow 0.9845 0.9931 
n 0.5402 0.7414 
k 8.1449 15.79 
Best fit First Peppas 
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The cumulative drug released from the optimized microsphere 
formulation containing lamivudine in 12 h was 95.49±4.05%. The in 
vitro drug release data from optimized drumstick mucilage-alginate 
microspheres of lamivudine and marketed tablet Lamivir were 
evaluated kinetically using various mathematical models like zero-
order, first-order, Higuchi, and Korsmeyer-Peppas. The accuracy and 
prediction ability of these models were established using the highest 
regression analysis. The result of the curve fitting (R2) into various 
mathematical models are given in table 5. The respective R2of 
optimized drumstick-alginate microspheres of lamivudine were 
compared, it was found to follow the Korsemeyer-Peppas model 
(R2= 0.9947). The best fit of the Korsemeyer-Peppas model shows 
that the lamivudine release from these optimized drumstick 
mucilage-alginate microspheres followed the controlled-release 
pattern. The values of diffusional exponent (n) determined from 
Korsmeyer-Peppas model was 0.7414(greater than 0.45), indicating 
the drug release from optimized formulation of drumstick mucilage-
alginate microspheres of lamivudine follows, non fickian release 
mechanism i.e., swelling followed by erosion of polymeric blend, 
This could be attributed due to polymer dissolution and polymeric 
chain enlargement or relaxation.  
CONCLUSION 
In this investigation, drumstick mucilage-alginate mucoadhesive 
microspheres of lamivudine were successfully developed and 
optimized. These developed optimized mucoadhesive microspheres 
demonstrated high drug encapsulation, sustained drug release 
profile at a controlled rate. Therefore, these drumstick mucilage-
alginate mucoadhesive microspheres of lamivudine were found 
suitable for prolonged systemic absorption of lamivudine through 
sustained drug release, resulting in improved patient compliance. 
Moreover, the technique for the preparation of these microspheres 
was found simple, economical, and consistent.  
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